CONMED Corporation

CNMD · NYSE · Stock · Healthcare
$44.93
-1.36% today
Delayed price,

What CONMED does

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as powered resection instruments, fluid management and visualization systems, and related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solutions comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures; and products to treat diseases of dilation, hemostasis, biliary, stricture management, and infection prevention, as well as ECG electrodes, EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Key facts

Sector
Healthcare
Industry
Medical Devices
Market cap
$1.35B
P/E (ttm)
24.3
Forward P/E
9.4
Dividend yield
0.00%
Beta
0.94
Profit margin
4.1%
Employees
3,900
Headquarters
Largo, FL, United States
Exchange
NYSE

Performance

1 Month
-1.1%
3 Months
+4.0%
6 Months
+15.0%
1 Year
-0.6%
5 Years
-65.8%
$31.4452-week range$53.66
Biggest setback — last 12 months
-31.8%
20 Oct 2025 → 15 Jun 2026
Fell from $47.76 to $32.58 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+56.8%
15 Jun 2026 → 17 Aug 2026
Ran from $32.58 to $51.07 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$39.71 (-11.6%)$44.93$50.84 (+13.2%)
3 Months$36.27 (-19.3%)$44.93$55.65 (+23.9%)
6 Months$33.19 (-26.1%)$44.93$60.81 (+35.4%)
12 Months$29.28 (-34.8%)$44.93$68.94 (+53.4%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 42.8%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Acquired 500 shares — Kelderman Kim, Director · 2026-09-10
Acquired 92,465 shares — Gallagher John E, Executive Vice President & CFO · 2026-07-17
Acquired 5,603 shares — Martin Celine Christine, Director · 2026-07-02
Acquired 5,603 shares — Mirviss Jeffrey B., Director · 2026-07-02
Acquired 668 shares — Bronson David M., Director · 2026-06-03
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.